登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 美年大健康产业控股股份有限公司（以下简称"公司"、"美年健康"）5%以上股东杭州信投信息技术有 限公司（以下简称"杭州信投"）于2025年7月23日至7月28日期间内通过大宗交易及集中竞价交易方式累 计减持公司36,579,778股股份，减持后杭州信投及其一致行动人杭州灏月企业管理有限公司合计持有的 美年健康股份比例由11.81%减少至10.88%。 证券代码：002044 证券简称：美年健康 公告编号：2025-053 美年大健康产业控股股份有限公司 关于5%以上股东权益变动触及1%刻度的公告 公司股东杭州信投信息技术有限公司保证向本公司提供的信息内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 ■■ 特此公告。 美年大健康产业控股股份有限公司 董 事 会 二〇二五年七月三十日 公司于2025年5月6日在巨潮资讯网（www.cninfo.com.cn）披露了《关于5%以上股东减持股份的预披露 公告》（公告编号：2025-027）。近日，公司收到杭州信投出具的《关于所持 ...

美年健康5%以上股东减持公告要点解读 7月23日：大宗交易减持1,410.39万股 7月25日：大宗交易减持1,665.12万股 7月28日：集中竞价减持582.47万股 持股变化 •杭州信投：持股比例从3.79%降至2.86% •杭州信投及一致行动人杭州灏月：合计持股比例从11.81%降 至10.88% •一致行动人杭州灏月：持股比例维持8.02%不变 核心事项 股东减持：5%以上股东杭州信投于2025年7月23-28日期间减持美年健康股份，触及1%刻度。 减持详情 •减持股数：3,657.98万股，占总股本0.93% •减持方式：大宗交易+集中竞价交易 •减持时间： 其他要点 • 本次减持按照此前5月6日预披露的减持计划执行 • 减持计划尚未履行完毕 • 不影响公司控制权及持续 经营 ...

证券代码：002044 证券简称：美年健康 公告编号：2025-053 美年大健康产业控股股份有限公司 关于 5%以上股东权益变动触及 1%刻度的公告 公司股东杭州信投信息技术有限公司保证向本公司提供的信息内容真实、 准确、完整，没有虚假记载、误导性陈述或重大遗漏。 董 事 会 二〇二五年七月三十日 特别提示： 美年大健康产业控股股份有限公司（以下简称"公司"、"美年健康"）5%以上 股东杭州信投信息技术有限公司（以下简称"杭州信投"）于 2025 年 7 月 23 日至 7 月 28 日期间内通过大宗交易及集中竞价交易方式累计减持公司 36,579,778 股 股份，减持后杭州信投及其一致行动人杭州灏月企业管理有限公司合计持有的美 年健康股份比例由 11.81%减少至 10.88%。 公司于 2025 年 5 月 6 日在巨潮资讯网（www.cninfo.com.cn）披露了《关于 5%以上股东减持股份的预披露公告》（公告编号：2025-027）。近日，公司收到 杭州信投出具的《关于所持美年健康股份变动的通知》，其减持触及美年健康总 股本 1%的刻度。现将相关情况公告如下： | 1、基本情况 | | | | ...

Core Viewpoint - The legal opinion from Beijing Tianyuan Law Firm confirms that the procedures for the 2025 first extraordinary general meeting of shareholders of Meinian Onehealth Healthcare Holdings Co., Ltd. were conducted in compliance with relevant laws and regulations, ensuring the legitimacy of the meeting and its resolutions [2][3][27]. Group 1: Meeting Procedures - The meeting was convened by the company's ninth board of directors on July 11, 2025, and the notice was published on July 12, 2025, detailing the time, location, and agenda [4][5]. - The meeting utilized a combination of on-site and online voting, held on July 28, 2025, at the company's conference room in Shanghai [4][6]. Group 2: Attendance and Voting - A total of 921 participants attended the meeting, holding 1,277,900,984 shares, which represents 32.6474% of the total voting shares [5][6]. - The voting included 528,253,450 shares from on-site attendees, accounting for 13.4956% of total shares, and 749,647,534 shares from online voters, representing 19.1517% [5][6]. Group 3: Voting Results - The resolutions were passed with significant support, with 1,272,894,440 shares voting in favor, which is approximately 99.9996% of the votes cast [6][7]. - For the minority investors, 282,237,144 shares voted in favor, representing 98.2570% of their total voting shares [6][7]. - All resolutions requiring a two-thirds majority were successfully approved, demonstrating strong shareholder support [6][7][8].

Meeting Overview - The shareholders' meeting of Meinian Health Industry Holdings Co., Ltd. was held on July 28, 2025, with a total of 921 participants representing 1,277,900,984 shares, accounting for 32.6474% of the total shares [1] - The online voting took place from 9:15 AM to 3:00 PM on the same day, with 916 shareholders participating, representing 749,647,534 shares, or 19.1517% of the total shares [2] Voting Results - The meeting adopted resolutions with a significant majority, where 1,272,894,440 shares voted in favor, representing 99.6082% of the valid votes [2] - A total of 4,509,144 shares opposed the resolutions, accounting for 0.3529%, while 497,400 shares were abstained [2] Minority Shareholder Participation - Among the minority investors, 282,237,144 shares voted in favor, which is 98.2570% of the valid votes from minority shareholders [3] - The opposition from minority shareholders was 4,509,144 shares, representing 1.5698% [3] Related Party Transactions - The resolutions involved related party transactions, with specific shareholders, including Yu Rong and several asset management companies, abstaining from voting [3][4] - The voting results from non-related shareholders showed 738,065,801 shares in favor, which is 98.4550% of the valid votes [4] Detailed Voting Breakdown - The detailed voting results indicated that among non-related minority shareholders, 275,661,955 shares voted in favor, representing 95.9680% [4] - The opposition from this group was 11,086,633 shares, accounting for 3.8597% [4] Conclusion of Resolutions - All resolutions requiring a two-thirds majority from non-related shareholders were successfully passed according to the company's articles of association [4][5] - The resolutions included significant related party transactions, with the relevant shareholders abstaining from the voting process [5][6]

北京市天元律师事务所 关于美年大健康产业控股股份有限公司 2025 年第一次临时股东大会的 法律意见 京天股字（2025）第 485 号 致：美年大健康产业控股股份有限公司 美年大健康产业控股股份有限公司（以下简称"公司"）2025 年第一次临时股 东大会（以下简称"本次股东大会"）采用现场投票与网络投票相结合的方式召开， 现场会议于 2025 年 7 月 28 日 14:50 在上海市静安区灵石路 697 号健康智谷 9 号楼 公司会议室召开。北京市天元律师事务所（以下简称"本所"）接受公司聘任，指派 本所律师参加本次股东大会现场会议，并根据《中华人民共和国公司法》、《中华 人民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》（以下 简称"《股东会规则》"）以及《美年大健康产业控股股份有限公司章程》（以下简 称"《公司章程》"）等有关规定，就本次股东大会的召集、召开程序、出席会议人 员的资格、召集人资格、会议表决程序和表决结果等有关事宜出具本法律意见。 为出具本法律意见，本所律师审查了《美年大健康产业控股股份有限公司第九 届董事会第十次（临时）会议决议公告》《美年大健康产业控股股份有限公司第 ...

证券代码：002044 证券简称：美年健康 公告编号：2025-052 美年大健康产业控股股份有限公司 2025 年第一次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会无否决或修改提案的情况，无涉及变更前次股东大会决议的 情况。 2、本次股东大会审议的议案2-22，出席会议的关联股东均已回避表决。 3、本次股东大会审议的全部议案已对中小投资者（指除上市公司的董事、监 事、高级管理人员以及单独或者合计持有上市公司5%以上股份的股东以外的股东） 的表决单独计票。 一、会议召开和出席情况 （一）会议召开情况 1、会议召开的时间 （1）现场会议召开时间：2025 年 7 月 28 日（星期一）下午 14:50 （2）网络投票时间为：2025 年 7 月 28 日（星期一）9:15-15:00 2、现场会议召开地点：上海市静安区灵石路 697 号健康智谷 9 号楼三楼公司 会议室 3、召开方式：现场投票与网络投票相结合的方式 4、会议召集人：公司董事会 5、会议主持人：公司董事长俞熔先生 1）通过深圳证券交易所交易系统 ...

Core Viewpoint - The law firm Junzejun has conducted a special verification of the stock trading activities of insiders related to the asset acquisition and related transactions of Meinian Health Industry Holdings Co., Ltd, confirming that no insider trading occurred during the self-examination period [1][11]. Group 1: Transaction Overview - Meinian Health has engaged Junzejun Law Firm to provide legal advice and issue a legal opinion regarding its issuance of shares for asset acquisition and related transactions [1][2]. - The self-examination period for insider trading activities spans from six months prior to the initial disclosure of the transaction plan until one day before the report was disclosed, specifically from April 14, 2024, to July 11, 2025 [3][4]. Group 2: Insider Trading Verification - The verification scope includes insiders and their immediate family members, such as spouses and children, who are involved in the stock trading activities during the self-examination period [4]. - A total of 33 individuals were identified as having engaged in stock trading activities during the self-examination period, with specific details on their trading activities documented [6][7]. Group 3: Compliance and Commitments - The law firm confirmed that the trading activities of the identified insiders and their family members were based on personal investment decisions and did not involve any insider information related to the transaction [10][11]. - Insiders have provided written commitments stating that their trading activities were independent and did not constitute insider trading, agreeing to forfeit any profits if found to be in violation of regulations [9][10].

Core Viewpoint - Meinian Health Industry Holdings Co., Ltd. is planning to acquire stakes in several health management companies through a share issuance, while ensuring compliance with insider trading regulations and confirming that no insider trading has occurred during the self-inspection period [1][2][12]. Group 1: Transaction Details - The company intends to acquire 84% of Hengyang Meinian Health Examination Center, 81% of Ningde Meinian Health Management, 75% of Yantai Meinian Health Management, and other significant stakes in various subsidiaries [2]. - The self-inspection period for insider trading activities spans from October 14, 2024, to July 11, 2025, covering six months prior to the initial disclosure of the transaction [3]. Group 2: Compliance and Self-Inspection - The company conducted a self-inspection of insider trading activities involving its directors, supervisors, senior management, and related parties during the specified period [3][4]. - The self-inspection confirmed that no insider trading occurred, as all involved parties provided declarations affirming their compliance with regulations [12][13]. Group 3: Financial Advisor and Legal Opinions - The independent financial advisor, Yuekai Securities, concluded that the trading activities during the self-inspection period did not constitute insider trading and would not pose legal obstacles to the transaction [12][13]. - The legal advisor, Beijing Junzejun Law Firm, also affirmed that the self-inspection reports and declarations were accurate and complete, indicating no insider trading violations [13].

证券代码：002044 证券简称：美年健康 公告编号：2025-051 美年大健康产业控股股份有限公司 关于发行股份购买资产暨关联交易相关主体 买卖股票情况自查报告的公告 特别提示： 根据中国证券登记结算有限责任公司深圳分公司出具的《信息披露义务人持 股及股份变更查询证明》《股东股份变更明细清单》以及交易相关主体签署的自 查报告、声明及承诺，在前述主体出具的自查报告、声明及承诺真实、准确、完 整的前提下，本次交易相关主体在自查期间买卖上市公司股票的行为不属于利用 本次交易的内幕信息进行的内幕交易行为，对本次交易不构成法律障碍。除上述 披露的情况外，在自查期间，本次交易其他内幕信息知情人及相关各方、相关人 员及其直系亲属不存在买卖上市公司股票的情况。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 美年大健康产业控股股份有限公司（以下简称"上市公司"、"公司"、"美年健 康"）拟通过发行股份的方式购买交易对方持有的衡阳美年健康体检中心有限公 司（以下简称"衡阳美年"）84.00%股权、宁德美年大健康管理有限公司（以下简 称"宁德美年"）81.00%股权、烟台美年 ...